Literature DB >> 16193081

Detection of MOZ-CBP fusion in acute myeloid leukemia with 8;16 translocation.

J A Crowley, Y Wang, A P Rapoport, Y Ning.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16193081     DOI： 10.1038/sj.leu.2403971

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

Review 1.  The MOZ histone acetyltransferase in epigenetic signaling and disease.

Authors:  Samuel Carlson; Karen C Glass
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

Review 2.  Chromatin modifiers and the promise of epigenetic therapy in acute leukemia.

Authors:  S M Greenblatt; S D Nimer
Journal:  Leukemia       Date:  2014-03-10       Impact factor: 11.528

Review 3.  Histone-modifying enzymes: their role in the pathogenesis of acute leukemia and their therapeutic potential.

Authors:  Ly P Vu; Luisa Luciani; Stephen D Nimer
Journal:  Int J Hematol       Date:  2013-01-04       Impact factor: 2.490

4.  Crystallization and preliminary X-ray diffraction analysis of the BRPF1 bromodomain in complex with its H2AK5ac and H4K12ac histone-peptide ligands.

Authors:  Mulu Y Lubula; Amanda Poplawaski; Karen C Glass
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-09-25       Impact factor: 1.056

Review 5.  Histone deacetylase inhibitors: current status and overview of recent clinical trials.

Authors:  Xujun Ma; Hany H Ezzeldin; Robert B Diasio
Journal:  Drugs       Date:  2009-10-01       Impact factor: 9.546

6.  The transcriptional coactivator Cbp regulates self-renewal and differentiation in adult hematopoietic stem cells.

Authors:  Wai-In Chan; Rebecca L Hannah; Mark A Dawson; Clare Pridans; Donna Foster; Anagha Joshi; Berthold Göttgens; Jan M Van Deursen; Brian J P Huntly
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

7.  Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer.

Authors:  Carol Lai-Hung Cheng; Felice Hoi-Ching Tsang; Lai Wei; Mengnuo Chen; Don Wai-Ching Chin; Jialing Shen; Cheuk-Ting Law; Derek Lee; Carmen Chak-Lui Wong; Irene Oi-Lin Ng; Chun-Ming Wong
Journal:  Commun Biol       Date:  2021-07-20

8.  The BRPF1 bromodomain is a molecular reader of di-acetyllysine.

Authors:  Juliet O Obi; Mulu Y Lubula; Gabriel Cornilescu; Amy Henrickson; Kara McGuire; Chiara M Evans; Margaret Phillips; Samuel P Boyson; Borries Demeler; John L Markley; Karen C Glass
Journal:  Curr Res Struct Biol       Date:  2020-05-12

9.  The impact of CBP expression in estrogen receptor-positive breast cancer.

Authors:  Wafaa S Ramadan; Iman M Talaat; Mahmood Y Hachim; Annette Lischka; Timo Gemoll; Raafat El-Awady
Journal:  Clin Epigenetics       Date:  2021-04-07       Impact factor: 6.551
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.